| Mr. Daniel Welch |
Independent Chairman of the Board |
65 |
$499.4K - USD |
Male |
|
| Dr. Emil Kakkis |
President, Chief Executive Officer, Director |
62 |
$12.14M - USD |
Male |
|
| Mr. Howard Horn |
Chief Financial Officer, Executive Vice President, Corporate Strategy |
46 |
- |
Male |
|
| Mr. Dennis Huang |
Executive Vice President, Chief Technical Operations Officer and Gene Therapy Operations |
58 |
$4.243M - USD |
Male |
|
| Ms. Karah Parschauer |
Executive Vice President, Chief Legal Officer, General Counsel |
45 |
$2.036M - USD |
Female |
|
| Mr. Eric Crombez |
Executive Vice President, Chief Medical Officer |
|
- |
Male |
|
| Mr. Erik Harris |
Executive Vice President, Chief Commercial Officer |
53 |
$3.749M - USD |
Male |
|
| Mr. Thomas Kassberg |
Chief Business Officer, Executive Vice President |
62 |
$2.457M - USD |
Male |
|
| Mr. John Pinion |
Chief Quality Officer, Executive Vice President - Translational Sciences |
57 |
$3.707M - USD |
Male |
|
| Dr. Deborah Dunsire |
Independent Director |
61 |
$462.2K - USD |
Female |
|
| Mr. Matthew Fust |
Independent Director |
58 |
$478.2K - USD |
Male |
|
| Mr. Michael Narachi |
Independent Director |
63 |
$481.3K - USD |
Male |
|
| Dr. Amrit Ray |
Independent Director |
50 |
$1.242M - USD |
Male |
|
| Dr. Corazon Sanders |
Independent Director |
66 |
$465.8K - USD |
Female |
|
| Dr. Shehnaaz Suliman |
Independent Director |
51 |
$466.4K - USD |
Female |
|
